Human Nutrition Unit, Faculty of Medicine and Health Sciences, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain.
PLoS One. 2012;7(8):e43275. doi: 10.1371/journal.pone.0043275. Epub 2012 Aug 14.
Several anthropometric measurements have been associated with cardiovascular disease, type-2 diabetes mellitus and other cardiovascular risk conditions, such as hypertension or metabolic syndrome. Waist-to-height-ratio has been proposed as a useful tool for assessing abdominal obesity, correcting other measurements for the height of the individual. We compared the ability of several anthropometric measurements to predict the presence of type-2 diabetes, hyperglycemia, hypertension, atherogenic dyslipidemia or metabolic syndrome.
In our cross-sectional analyses we included 7447 Spanish individuals at high cardiovascular risk, men aged 55-80 years and women aged 60-80 years, from the PREDIMED study. Logistic regression models were fitted to evaluate the odds ratio of presenting each cardiovascular risk factor according to various anthropometric measures. The areas under the receiver-operating characteristic curve (AUC) were used to compare the predictive ability of these measurements.
In this relatively homogeneous cohort with 48.6% of type-2 diabetic individuals, the great majority of the studied anthropometric parameters were significantly and positively associated with the cardiovascular risk factors. No association was found between BMI and body weight and diabetes mellitus. The AUCs for the waist-to-height ratio and waist circumference were significantly higher than the AUCs for BMI or weight for type-2 diabetes, hyperglycemia, atherogenic dyslipidemia and metabolic syndrome. Conversely, BMI was the strongest predictor of hypertension.
We concluded that measures of abdominal obesity showed higher discriminative ability for diabetes mellitus, high fasting plasma glucose, atherogenic dyslipidemia and metabolic syndrome than BMI or weight in a large cohort of elderly Mediterranean individuals at high cardiovascular risk. No significant differences were found between the predictive abilities of waist-to-height ratio and waist circumference on the metabolic disease.
几种人体测量学指标与心血管疾病、2 型糖尿病和其他心血管风险状况(如高血压或代谢综合征)相关。腰高比已被提出作为评估腹部肥胖的有用工具,用于校正个体身高的其他测量值。我们比较了几种人体测量学指标预测 2 型糖尿病、高血糖、高血压、动脉粥样硬化性血脂异常或代谢综合征的能力。
在我们的横断面分析中,我们纳入了来自 PREDIMED 研究的 7447 名西班牙高心血管风险人群,年龄在 55-80 岁的男性和 60-80 岁的女性。我们拟合了逻辑回归模型来评估根据各种人体测量学指标呈现每种心血管危险因素的优势比。我们使用接受者操作特征曲线下的面积(AUC)来比较这些测量方法的预测能力。
在这个相对同质的队列中,有 48.6%的 2 型糖尿病患者,大多数研究的人体测量参数与心血管危险因素显著正相关。BMI 和体重与糖尿病之间没有关联。腰高比和腰围的 AUC 显著高于 BMI 或体重对 2 型糖尿病、高血糖、动脉粥样硬化性血脂异常和代谢综合征的 AUC。相反,BMI 是高血压最强的预测因素。
我们得出结论,在一个高心血管风险的老年地中海人群中,腹部肥胖的测量指标对糖尿病、高空腹血糖、动脉粥样硬化性血脂异常和代谢综合征的鉴别能力高于 BMI 或体重。腰高比和腰围在代谢疾病方面的预测能力没有显著差异。